Product Description

Abevmy 400 mg Injection contains Bevacizumab 400 mg, a targeted anticancer medicine belonging to the monoclonal antibody class. It is used in combination with other cancer treatments for several types of cancer and is administered by intravenous infusion under specialist oncology supervision.

🔹 Key Uses

Metastatic colorectal cancer
Certain types of lung cancer
Ovarian cancer
Cervical cancer
Kidney cancer
Glioblastoma in selected patients
Other cancers where Bevacizumab is included in the prescribed treatment protocol

🔹 Composition
Active ingredient: Bevacizumab 400 mg
Medicine class: Anti-VEGF monoclonal antibody
Dosage form: Intravenous infusion

🔹 How It Works
Bevacizumab blocks vascular endothelial growth factor (VEGF), a protein that promotes the formation of new blood vessels. By inhibiting VEGF, it can reduce the blood supply that tumors need for growth and may help slow cancer progression.

🔹 Key Benefits

Helps slow the growth of certain cancers
Targets blood vessel formation that supports tumor growth
Can be combined with chemotherapy or other anticancer medicines
Provides targeted treatment for selected cancers
May help control disease progression in appropriate patients

🔹 Dosage and Administration
The dose and treatment schedule depend on the cancer type, body weight, treatment regimen, overall health, and response to therapy.

Administered by intravenous infusion by trained healthcare professionals.
Blood pressure and urine protein may need regular monitoring.
Treatment may need to be temporarily withheld around major surgery because Bevacizumab can impair wound healing.
Do not self-administer or change the prescribed treatment schedule.

🔹 Possible Side Effects

High blood pressure
Headache
Tiredness
Nausea
Diarrhea
Loss of appetite
Mouth sores
Nosebleeds
Protein in urine
Infusion-related reactions

Serious complications can include severe bleeding, blood clots, gastrointestinal perforation, kidney problems, impaired wound healing, and severe hypertension.

🔹 Precautions and Warnings

Use only under specialist oncology supervision.
Inform your doctor about high blood pressure, bleeding disorders, blood clots, recent surgery, kidney problems, or gastrointestinal conditions.
Regular blood pressure and urine monitoring may be required.
Bevacizumab can impair wound healing and may need to be stopped before and after major surgery.
Tell your doctor about all medicines, supplements, and cancer treatments you are receiving.
Seek immediate medical attention for severe abdominal pain, heavy bleeding, chest pain, difficulty breathing, severe headache, or sudden weakness.